| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.06B | 99.25B | 96.97B | 88.66B | 82.47B | 87.58B |
| Gross Profit | 8.66B | 7.53B | 4.71B | 6.59B | 6.60B | 7.04B |
| EBITDA | 4.90B | 3.88B | 763.00M | 2.77B | 3.00B | 3.55B |
| Net Income | 3.42B | 2.73B | 1.16B | 1.70B | 1.79B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 75.35B | 81.42B | 78.61B | 72.38B | 69.92B | 74.43B |
| Cash, Cash Equivalents and Short-Term Investments | 12.86B | 13.46B | 9.29B | 21.50B | 15.90B | 19.60B |
| Total Debt | 3.95B | 3.17B | 5.18B | 209.00M | 229.00M | 242.59M |
| Total Liabilities | 24.21B | 30.80B | 30.99B | 28.21B | 27.03B | 31.90B |
| Stockholders Equity | 51.13B | 50.62B | 47.62B | 44.17B | 42.88B | 42.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.99B | -16.83B | 6.61B | -2.66B | 6.30B |
| Operating Cash Flow | 0.00 | 7.62B | -16.19B | 7.18B | -20.00M | 7.08B |
| Investing Cash Flow | 0.00 | -177.00M | -18.00M | -543.00M | -2.34B | -983.62M |
| Financing Cash Flow | 0.00 | -3.07B | 3.80B | -923.00M | -1.40B | -797.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥51.67B | 6.41 | ― | 3.97% | 2.85% | 317.62% | |
77 Outperform | ¥43.04B | 6.66 | ― | 3.88% | 4.11% | 28.37% | |
76 Outperform | ¥42.38B | 7.43 | 7.09% | 3.06% | -5.41% | 5.68% | |
75 Outperform | ¥52.68B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
73 Outperform | ¥48.08B | 7.92 | ― | 1.96% | 2.55% | -14.37% | |
67 Neutral | ¥50.75B | 11.76 | ― | 2.19% | 5.45% | 86.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |